Artwork

Content provided by NFX. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NFX or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Past, Present, and Future of Longevity w/ Joe Betts-LaCroix Alex Colville

38:19
 
Share
 

Manage episode 411750620 series 2528675
Content provided by NFX. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NFX or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global fundraising potential and societal impact of the longevity sector, viewing aging as a disease, and the future of longevity drugs. Learn more at - https://nfx.com/bio (0:00) Introduction and Overview of Longevity Science (4:21) Transition from Scientist to Investor: Alex Colville's Journey (8:16) Current Advancements in Biology and Aging Field (12:15) Cutting Edge Topics in Longevity Space (20:02) Evaluating Potential Founders and Startups in the Longevity Space (22:08) Challenges in Longevity Field: FDA Approval and Mission Focus (23:46) Risks and Investment in the Biotech Industry (27:24) Misconceptions and Business Case for Longevity (32:34) Societal Effects and Impact of Longevity Drugs (36:08) Advice and Future Challenges for Founders in the Longevity Field (38:04) Closing Remarks and Thanks
  continue reading

171 episodes

Artwork
iconShare
 
Manage episode 411750620 series 2528675
Content provided by NFX. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NFX or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, Omri Amirav-Drory (NFX), Joe Betts-LaCroix (Retro Bio), and Alex Colville (Age1) discuss the history, recent progress, and hurdles in the longevity industry, including the evaluation of potential founders and business risks. The discussion further encompasses the global fundraising potential and societal impact of the longevity sector, viewing aging as a disease, and the future of longevity drugs. Learn more at - https://nfx.com/bio (0:00) Introduction and Overview of Longevity Science (4:21) Transition from Scientist to Investor: Alex Colville's Journey (8:16) Current Advancements in Biology and Aging Field (12:15) Cutting Edge Topics in Longevity Space (20:02) Evaluating Potential Founders and Startups in the Longevity Space (22:08) Challenges in Longevity Field: FDA Approval and Mission Focus (23:46) Risks and Investment in the Biotech Industry (27:24) Misconceptions and Business Case for Longevity (32:34) Societal Effects and Impact of Longevity Drugs (36:08) Advice and Future Challenges for Founders in the Longevity Field (38:04) Closing Remarks and Thanks
  continue reading

171 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide